“An Insurance Company Doing the Right Thing” –not The Onion headline this time.

Recently (April 7. 2019) United Healthcare put out a policy statement explicitly stating:

“Fecal measurement of calprotectin is proven and medically necessary for establishing the diagnosis or for management of the following:

• Crohn’s Disease
• Ulcerative Colitis”

Thanks to Kim Conn for identifying this policy.

The policy statement provides an in-depth rationale for why calprotectin is medically-indicated along with supporting recommendations from multiple GI societies and National Institute for Health and Care Excellence (NICE).  The policy statement includes a long list of references and would provide a strong argument in supporting calprotectin testing for all insurance providers.

Here’s the link: FECAL CALPROTECTIN TESTING United Healthcare.

Related blog posts:

• Keep the Stool Cool for More Reliable Calprotectin Testing
• Calprotectin in Triaging Potential Pediatric IBD Cases
• Biomarkers identify patients who benefit and how
• Fecal Calprotectin Monitoring for IBD Relapse
• Best Fecal Marker for Crohn’s Disease: Calprotectin | gutsandgrowth
• Value of Calprotectin | gutsandgrowth
• Prospective Monitoring of Calprotectin for Crohn’s Disease …

Lots of lazy river floating. Deschutes River, Bend OR